ARID1A and colorectal cancer: Previous pan-cancer analyses have uncovered the significance of aberrantly expressed genes in the onset and/or progression of colorectal cancer; for instance, ARID1A alterations impair mismatch repair pathways and increase the number of tumor-infiltrating lymphocytes and PD-L1 expression in gastric cancer.